Pcn283 - Identifying the Key Challenges Affecting the Reimbursement of Car-T Therapies in the Eu5 Using a Web-Based Portal to Engage Payers

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.365
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Php222 - Identifying the Key Drivers Affecting the Reimbursement of Therapeutic Vaccines in Eu5 Countries Using a Web-Based Portal to Engage Payers

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Php245 - Understanding the Impact of Real World Evidence on Reimbursement Decisions Across Eu5 Countries Using a Web-Based Portal to Engage Payers

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcn235 - Combination Oncology Therapies in the Eu5: Navigating the Road to Reimbursement and Optimizing Uptake in Malignant Melanoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pnd92 - Access and Reimbursement for Current and Emerging Alzheimer’s Disease-Modifying Therapies in the Eu5

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Primary Bone Tumors: Challenges and Opportunities for CAR‐T Therapies

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2019English

Time to Reimbursement for Oncology Drugs in EU5

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Challenges of Driving CD30-directed CAR-T Cells to the Clinic

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Can Hospitals and Physicians Shift the Effects of Cuts in Medicare Reimbursement to Private Payers?

Health Affairs
MedicineHealth Policy
2003English

Targeting T Cell Malignancies Using CAR-based Immunotherapy: Challenges and Potential Solutions

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy